Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.44Last Year’s EPS
-0.62Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: -26.05%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
Inogen's earnings call highlighted notable achievements in revenue growth, strategic collaborations, and product innovations, contributing positively to the company's outlook. However, challenges remain with declines in direct-to-consumer and rental revenues, alongside a continued net loss. The positive aspects, especially strategic partnerships and product clearances, suggest optimism for future growth.Company Guidance
During the fourth quarter 2024 earnings call, Inogen provided detailed guidance for 2025, highlighting several key metrics. The company expects first quarter 2025 revenue to range from $79 million to $81 million, representing 1% to 4% growth compared to the first quarter of 2024. Full-year 2025 revenue is projected between $352 million and $355 million, indicating a 5% to 6% increase over 2024. Inogen anticipates gross margins for 2025 to be between 43% and 45%, influenced by the introduction of Simeox and Yuwell products. The company aims to reach adjusted EBITDA breakeven by managing expenses while leveraging its existing cost structure. Significant growth is expected in the business-to-business channel, while the direct-to-consumer channel faces challenges due to a reduced sales force. Inogen's collaboration with Yuwell, which recently closed, is not expected to significantly impact 2025 results immediately, but it is anticipated to contribute positively in the future.Revenue Growth
Inogen delivered over $335 million in revenue for 2024, representing a 6.4% growth over the prior year. Fourth quarter revenue achieved was over $80 million, reflecting a 5.5% year-over-year growth.
Strategic Collaboration with Yuwell Medical
Inogen announced a collaboration and investment from Yuwell Medical, expediting entry into the Chinese market and adding $27 million in capital with a 9.9% ownership stake.
FDA Clearance for Simeox Device
In December, Inogen received FDA 510(k) clearance for the Simeox airway clearance device, expanding its product portfolio and addressing a larger patient population.
Improved Profitability Metrics
Inogen reported two quarters of adjusted EBITDA profitability in 2024 and expects continued improvement in 2025.
Advancements in Digital Health Offerings
Inogen launched updates to its digital health offerings, enhancing device connectivity and remote accessibility for patients and partners.
---
INGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $9.52 | $8.11 | -14.81% |
| Nov 07, 2024 | $9.46 | $11.09 | +17.23% |
| Aug 06, 2024 | $8.15 | $11.08 | +35.95% |
| May 07, 2024 | $7.30 | $8.24 | +12.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Inogen (INGN) report earnings?
Inogen (INGN) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Inogen (INGN) earnings time?
Inogen (INGN) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INGN EPS forecast?
INGN EPS forecast for the fiscal quarter 2025 (Q1) is -0.44.
---